224 related articles for article (PubMed ID: 25410148)
1. Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.
Sharma A; Thakar S; Lavie CJ; Garg J; Krishnamoorthy P; Sochor O; Arbab-Zadeh A; Lichstein E
Curr Cardiol Rep; 2015 Jan; 17(1):554. PubMed ID: 25410148
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database.
Kotz D; Simpson C; Viechtbauer W; van Schayck OC; West R; Sheikh A
BMJ Open; 2014 Aug; 4(8):e005281. PubMed ID: 25168037
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.
Mills EJ; Thorlund K; Eapen S; Wu P; Prochaska JJ
Circulation; 2014 Jan; 129(1):28-41. PubMed ID: 24323793
[TBL] [Abstract][Full Text] [Related]
5. Smoking cessation-recent advances.
McNeil JJ; Piccenna L; Ioannides-Demos LL
Cardiovasc Drugs Ther; 2010 Aug; 24(4):359-67. PubMed ID: 20602163
[TBL] [Abstract][Full Text] [Related]
6. Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
Cinciripini PM; Robinson JD; Karam-Hage M; Minnix JA; Lam C; Versace F; Brown VL; Engelmann JM; Wetter DW
JAMA Psychiatry; 2013 May; 70(5):522-33. PubMed ID: 23536105
[TBL] [Abstract][Full Text] [Related]
7. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
[TBL] [Abstract][Full Text] [Related]
8. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
9. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
Hays JT; Ebbert JO
Drugs; 2010 Dec; 70(18):2357-72. PubMed ID: 21142259
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of combination therapy for smoking cessation.
Shah SD; Wilken LA; Winkler SR; Lin SJ
J Am Pharm Assoc (2003); 2008; 48(5):659-65. PubMed ID: 18826906
[TBL] [Abstract][Full Text] [Related]
11. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
[TBL] [Abstract][Full Text] [Related]
12. Adapting smoking cessation treatment according to initial response to precessation nicotine patch.
Rose JE; Behm FM
Am J Psychiatry; 2013 Aug; 170(8):860-7. PubMed ID: 23640009
[TBL] [Abstract][Full Text] [Related]
13. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for smoking cessation: present and future.
Aubin HJ; Karila L; Reynaud M
Curr Pharm Des; 2011; 17(14):1343-50. PubMed ID: 21524268
[TBL] [Abstract][Full Text] [Related]
15. Suicidal behavior and depression in smoking cessation treatments.
Moore TJ; Furberg CD; Glenmullen J; Maltsberger JT; Singh S
PLoS One; 2011; 6(11):e27016. PubMed ID: 22073240
[TBL] [Abstract][Full Text] [Related]
16. Smoking cessation: an overview of treatment options with a focus on varenicline.
Stack NM
Pharmacotherapy; 2007 Nov; 27(11):1550-7. PubMed ID: 17963463
[TBL] [Abstract][Full Text] [Related]
17. Varenicline and bupropion: suicide.
Prescrire Int; 2012 Oct; 21(131):240. PubMed ID: 23189376
[No Abstract] [Full Text] [Related]
18. Breaking free from nicotine dependence. A combination of strategies boosts the odds of success.
Harv Ment Health Lett; 2011 Apr; 27(10):1-3. PubMed ID: 21786468
[No Abstract] [Full Text] [Related]
19. [Current and future medical drugs for smoking cessation].
Kusma B; Mache S; Deissenrieder F; Quarcoo D; Welte T; Groneberg D
Laryngorhinootologie; 2009 Jun; 88(6):410-9; quiz 420-2. PubMed ID: 19504411
[TBL] [Abstract][Full Text] [Related]
20. Treatment of nicotine dependence with Chantix (varenicline).
Rankin KV; Jones DL
Tex Dent J; 2011 May; 128(5):457-61. PubMed ID: 21834368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
